What to know about the Ebola outbreak - BERITAJA

The Ebola outbreak successful the Democratic Republic of Congo has grown to about 500 suspected cases and 116 deaths, the United Nations said Monday.

Among the cases is an American who contracted the virus while moving successful the DRC and will beryllium taken to Germany for treatment, the Centers for Disease Control and Prevention said Monday. Six different Americans will besides beryllium sent to Germany for observation. None are scheduled to beryllium sent backmost to the U.S.

On Sunday, the World Health Organization declared the outbreak, which has dispersed into Uganda, a nationalist wellness emergency of world concern.

The outbreak is being driven by a type of Ebola called Bundibugyo. Here’s what to know.

What is Bundibugyo, the type of Ebola successful the outbreak?

There are 4 type of the Ebolavirus that are known to origin illness successful humans, according to the CDC. Bundibugyo is 1 of the little communal types. This is conscionable the 3rd clip Bundibugyo has been implicated successful a known outbreak.

Bundibugyo was discovered little than 20 years agone successful occidental Uganda. Experts judge that consequence bats are the apt carriers of the virus.

How does Bundibugyo spread?

Like different types of Ebola that dispersed among humans, the Bundibugyo microorganism spreads easy done humor and different bodily fluids, arsenic good arsenic contaminated surfaces.

Handling dormant bodies is besides a known consequence for dispersed of the virus.

What are the symptoms of the Bundibugyo Ebolavirus?

Like different types of Ebola, the microorganism causes hemorrhagic fever.

The early symptoms are for illustration about viruses: fever, headache, sore throat, fatigue and achy muscles.

As the microorganism sets in, group besides acquisition monolithic tummy issues, including vomiting and diarrhea. Hemorrhagic fever occurs arsenic the microorganism affects the body’s humor vessels, damaging captious organs.

The incubation play for the microorganism is up to 21 days, according to WHO.

How deadly is the Bundibugyo virus?

Dr. Geeta Sood, a infirmary epidemiologist astatine Johns Hopkins Bayview Medical Center, said the Bundibugyo microorganism has a mortality complaint of about 25% to 40%, little than different types of Ebola, which mean about 50% to 60%.

The mortality complaint for the Zaire type, the about communal type of Ebola, is 60% to 90%, according to a 2015 study.

Are Americans astatine consequence for Ebola?

There are nary cases successful the U.S. and the threat to the U.S. “remains low,” Dr. Satish Pillai, caput of CDC’s Ebola response, said Monday during a media briefing.

The past clip Americans were straight progressive pinch Ebola was successful 2014, erstwhile an outbreak ravaged parts of West Africa. That outbreak was caused by the Zaire type of Ebola.

The outbreak lasted for 2 years, infecting astatine slightest 28,600 group and sidesplitting astatine slightest 11,325. The immense mostly of cases were successful Guinea, Liberia and Sierra Leone. Cases besides stretched into Italy, Mali, Nigeria, Senegal, Spain, the United Kingdom and the United States.

The first American diagnosed successful that outbreak, Dr. Kent Brantly, was evacuated to Emory University Hospital successful Atlanta successful August 2014 for treatment. Brantly had been moving pinch the aesculapian ngo Samaritan’s Purse treating Ebola patients successful Liberia erstwhile he contracted the virus. Brantly later recovered.

Ten different Ebola patients were treated successful the U.S. successful 2014. Like Brantly, about were evacuated from Africa. Two patients died.

Are location immoderate treatments aliases vaccines for Bundibugyo?

There are presently nary approved vaccines aliases treatments for the Bundibugyo virus.

The only 2 approved vaccines for Ebola — from Johnson & Johnson and Merck — target the Zaire type, the about lethal Ebola strain, which is responsible for the mostly of outbreaks successful Central and West Africa.

Sood, of Johns Hopkins Bayview Medical Center, said animal studies show those vaccines don’t supply bully protection against Bundibugyo.

Dr. Paul Offit, head of the Children’s Hospital of Philadelphia’s Vaccine Education Center, said location appears to beryllium a fistful of experimental vaccines for the Bundibugyo microorganism successful early improvement crossed the globe, but nary person reached quality trials.

That includes an mRNA-based vaccine successful China designed to target 3 strains, including the Bundibugyo virus, according to a study published Monday successful the diary Proceedings of the National Academy of Sciences. That vaccine is still successful the pre-clinical shape and has not been studied successful humans.

It will apt return years, however, earlier immoderate vaccine is fresh for quality testing, Sood said.

Pillai, of the CDC, said the agency is besides looking into imaginable treatments, including moving pinch different agencies successful the Health Department to create a monoclonal antibody, a type of lab-made macromolecule designed to mimic the body’s immune response.

Because location are nary treatments, supportive attraction will beryllium very important for anyone who becomes infected pinch the virus, Sood said.

“There is simply a batch we could do successful position of supporting personification for terrible illness,” she said. “Making judge they’re hydrated, checking their humor pressure, that if they are having problems aliases dysfunction pinch the bosom and lungs, that location are professionals and instrumentality about that we would usage to support the person.”